Today, Acarix announced the successful completion of a financing round raising 33.4 million SEK before costs. Both existing major shareholders and new long-term investors participated, and the subscription price was set at 0.285 SEK corresponding to a modest discount of 7.9% compared to Friday's closing price.
As our CEO Jan Poulsen is the chairman...
Today, Sprint Bioscience announced that they sold the pre-clicical Trex1 cancer program to Gilead Sciences, Inc. for USD 14 million up front and with potential clinical, regulatory, and commercial milestone payments totaling up to USD 400 million.
As part of our due diligence when entering into our investment in Sprint Bioscience back in May, we at...
Friday, SciBase released several announcements.
Firstly; Q3 numbers were released showing good growth across the board and with especially good traction in the US. Also good to see, that opex is well under control.
Secondly; it was announced that SciBase offers to repurchase its outstanding TO2's and pay with shares. The vast amount of TO2's with...
We are happy to have accepted an invite to participate in Biostock Life Science Summit 2025 in Lund the coming two days. We look forward to meeting both new companies and companies already in our portfolio as well as attending events and panel discussions.
Yesterday, LSIF participated in the accelerated bookbuilding process, which resulted in FluoGuide A/S (Nasdaq: FLUO) successfully raising SEK 104 million.
The proceeds will finance the execution of a Phase II clinical trial with FG001 in HGG in the US and a Phase II clinical trial with FG001 in head and neck cancer, as well as starting the...
This week, BiBBInstruments AB released news that the first commercial order for EndoDrill® GI has been received from the US market. At an investor presentation in Denmark, CEO Fredrik Lindblad later revealed that also a second order has been received. Although modest in financial impact, these orders mark an important milestone for BiBBInstruments...
This week, AcuCort AB announced that Anna Chérouvrier Hansson has been appointed as Business Development Director. This new position is part of AcuCort AB's reinforced focus on business development into new markets through strategic partnerships to support the launch of Zeqmelit®. Anna Hansson brings more than 15 years of experience in business...
LSIF has today completed a significant increase in ownership in SciBase by acquiring 7,5 million shares in an off-market transaction.
Today, Acarix has announced that yet another payer has granted USD 300 in fixed reimbursement for use of the CADScor test. As fixed reimbursement in our view is of major importance for parts of the US business case, it is encouraging to see that a dedicated effort and long-term work now is yielding results.
Today, Acarix announced very good news regarding obtaining the first significant international order in new geographical markets, which is the first step in an expansion into new markets.
Due to our CEO Jan Poulsen being the chairman of the board in Acarix, we refrain from commenting further on this news but refer to the company's press release ...